Cargando…

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hydes, Theresa J., Ravi, Sujan, Loomba, Rohit, E. Gray, Meagan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641567/
https://www.ncbi.nlm.nih.gov/pubmed/32674529
http://dx.doi.org/10.3350/cmh.2020.0067
_version_ 1783605943269851136
author Hydes, Theresa J.
Ravi, Sujan
Loomba, Rohit
E. Gray, Meagan
author_facet Hydes, Theresa J.
Ravi, Sujan
Loomba, Rohit
E. Gray, Meagan
author_sort Hydes, Theresa J.
collection PubMed
description Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest weight loss of ≥10% overall body weight is beneficial in resolving steatosis and reversing fibrosis. Prospective trials comparing various diets are limited by lack of sufficient power as well as pre- and post-treatment histopathology, and therefore no specific diet is recommended at this time. In this narrative review we examine the pathophysiology behind specific macronutrient components that can either promote or reverse NAFLD to help inform more specific dietary recommendations. Overall, the data supports reducing saturated fat, refined carbohydrates, and red and processed meats in the diet, and increasing the consumption of plant-based foods. Diets that incorporate these recommendations include plant-based diets such as the Dietary Approaches to Stop Hypertension, Mediterranean, vegetarian, and vegan diets.
format Online
Article
Text
id pubmed-7641567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-76415672020-11-13 Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH Hydes, Theresa J. Ravi, Sujan Loomba, Rohit E. Gray, Meagan Clin Mol Hepatol Review Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest weight loss of ≥10% overall body weight is beneficial in resolving steatosis and reversing fibrosis. Prospective trials comparing various diets are limited by lack of sufficient power as well as pre- and post-treatment histopathology, and therefore no specific diet is recommended at this time. In this narrative review we examine the pathophysiology behind specific macronutrient components that can either promote or reverse NAFLD to help inform more specific dietary recommendations. Overall, the data supports reducing saturated fat, refined carbohydrates, and red and processed meats in the diet, and increasing the consumption of plant-based foods. Diets that incorporate these recommendations include plant-based diets such as the Dietary Approaches to Stop Hypertension, Mediterranean, vegetarian, and vegan diets. The Korean Association for the Study of the Liver 2020-10 2020-07-17 /pmc/articles/PMC7641567/ /pubmed/32674529 http://dx.doi.org/10.3350/cmh.2020.0067 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Hydes, Theresa J.
Ravi, Sujan
Loomba, Rohit
E. Gray, Meagan
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title_full Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title_fullStr Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title_full_unstemmed Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title_short Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
title_sort evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of nafld and nash
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641567/
https://www.ncbi.nlm.nih.gov/pubmed/32674529
http://dx.doi.org/10.3350/cmh.2020.0067
work_keys_str_mv AT hydestheresaj evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash
AT ravisujan evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash
AT loombarohit evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash
AT egraymeagan evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash